Gout; Ivan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gout; Ivan.The latest application filed is for "membrane transporter napi2b (scl34a2) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy".

Company Profile

1.14.14

Gout; Ivan - London GB
Gout; Ivan - Ruislip GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibodies directed to membrane transporter NaP12b (SLC34A2) and uses thereof in cancer therapy Grant 10,385,138 - Ritter , et al. A	2019-08-20
Membrane Transporter NaPi2b (SCL34A2) Epitope for Antibody Therapy, Antibodies Directed Thereto, and Target for Cancer Therapy App 20170362336 - Ritter; Gerd ; et al.	2017-12-21
Membrane transporter NaPi2b (SCL34A2) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy Grant 9,701,755 - Ritter , et al. July 11, 2	2017-07-11
TRUNCATED VARIANT OF THE MAMMALIAN TARGET FOR RAPAMYCIN (mTOR) PROTEIN App 20170145391 - Nemazanyy; Ivan ; et al.	2017-05-25
Three-dimensional Cell Culture Using Nanofiber Slurries And Nano-structured Substrates App 20160257927 - Luo; Chaojie ; et al.	2016-09-08
Membrane Transporter NaPi2b (SCL34A2) Epitope for Antibody Therapy, Antibodies Directed Thereto, and Target for Cancer Therapy App 20160009816 - Ritter; Gerd ; et al.	2016-01-14
Membrane transporter NaPi2b (SCL34A2) epitope antibodies Grant 9,045,533 - Ritter , et al. June 2, 2	2015-06-02
Membrane Transporter NaPi2b (SCL34A2) Epitope for Antibody Therapy, Antibodies Directed Thereto, and Target for Cancer Therapy App 20140193417 - Ritter; Gerd ; et al.	2014-07-10
TRUNCATED VARIANT OF THE MAMMALIAN TARGET FOR RAPAMYCIN (mTOR) PROTEIN App 20140120099 - Nemazanyy; Ivan ; et al.	2014-05-01
Truncated variant of the mammalian target for rapamycin (MTOR) protein Grant 8,669,347 - Nemazanyy , et al. March 11, 2	2014-03-11
Membrane transporter NaPi2b (SCL34A1) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy Grant 8,603,474 - Ritter , et al. December 10, 2	2013-12-10
Identification and functional characterization of a novel ribosomal S6 protein kinase Grant 7,998,718 - Gout , et al. August 16, 2	2011-08-16
Membrane transporter NaPi2b (SCL34A1) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy App 20110129483 - Ritter; Gerd ; et al.	2011-06-02
Truncated Variant Of The Mammalian Target For Rapamycin (mtor) Protein App 20100247542 - Nemazanyy; Ivan ; et al.	2010-09-30
Regulation of S6 Kinsase Protein Activity and Related Methods App 20090181003 - Gout; Ivan ; et al.	2009-07-16
Method for determining expression of a PI3 kinase gene Grant 7,422,849 - Hiles , et al. September 9, 2	2008-09-09
Breast cancer antigens Grant 7,335,467 - Scanlan , et al. February 26, 2	2008-02-26
Identification and functional characterization of a novel ribosomal S6 protein kinase App 20050158748 - Gout, Ivan ; et al.	2005-07-21
Identification and functional characterization of a novel ribosomal S6 protein kinase Grant 6,830,909 - Gout , et al. December 14, 2	2004-12-14
Breast cancer antigens App 20030108888 - Scanlan, Matthew J. ; et al.	2003-06-12
Polypeptides having kinase activity, their preparation and use Grant 5,846,824 - Hiles , et al. December 8, 1	1998-12-08
Polypeptides having kinase activity, their preparation and use Grant 5,824,492 - Hiles , et al. October 20, 1	1998-10-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.